Similarly, lung adenocarcinoma data showed a significant 8-month reduction in the 0.5 overall survival probabilities of patients with high La mRNA expression, when compared to patients with low La mRNA expression (Figure 2B). This evidence concerns the gene SSB and lung adenocarcinoma.